BioMarin Pharmaceutical
Insider trading & Transactions

Last updated: 5 Jul 2007

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	5 Jul 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,000	$18.25	$36,490
Option	2 Jul 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$4	$50,000
Sale	2 Jul 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$18.2	$227,550
Option	2 Jul 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Stock Option (right to buy)	12,500	$4	$50,000
Sale	25 Jun 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,500	$17.65	$44,125
Option	7 Jun 2007	WOOD MARK officer: VP, Human Resources officer: VP, Human Resources	Common Stock	1,045	$8.08	$8,444
Option	7 Jun 2007	WOOD MARK officer: VP, Human Resources officer: VP, Human Resources	Stock Option (right to buy)	1,045	$8.08	$8,444
Sale	7 Jun 2007	WOOD MARK officer: VP, Human Resources officer: VP, Human Resources	Common Stock	1,045	$17.54	$18,332
Sale	4 Jun 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,500	$18.39	$45,975
Option	1 Jun 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to Buy)	10,000	$6.46	$64,600
Option	1 Jun 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	10,000	$6.46	$64,600
Sale	1 Jun 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	10,000	$18.38	$183,830
Sale	21 May 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,000	$18.54	$37,082
Sale	3 May 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	15,000	$16.31	$244,605
Option	3 May 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	15,000	$6.46	$96,900
Option	3 May 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Title of Security Stock Option (Right to buy)	1,500	$6.46	$9,690
Sale	2 May 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,500	$16.49	$24,738
Purchase	30 Apr 2007	KAKKIS EMIL D officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	2,982	$5.19	$15,462
Purchase	30 Apr 2007	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Common Stock	2,607	$5.19	$13,517
Purchase	30 Apr 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,553	$6.92	$17,664
Purchase	30 Apr 2007	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Common Stock	2,066	$6.92	$14,295
Purchase	30 Apr 2007	BAFFI ROBERT officer: President, Global Mfg/Tech Ops officer: President, Global Mfg/..	Common Stock	2,684	$5.19	$13,917
Sale	4 Apr 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,800	$17.76	$85,258
Option	4 Apr 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (right to buy)	5,000	$6.46	$32,300
Option	4 Apr 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	5,000	$6.46	$32,300
Option	2 Apr 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Stock Option (right to buy)	12,500	$4	$50,000
Option	2 Apr 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$4	$50,000
Sale	2 Apr 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$17.38	$217,263
Sale	7 Mar 2007	KLEIN JOSEPH III director director	Common Stock	12,000	$16.37	$196,464
Sale	2 Mar 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,500	$16.48	$24,725
Option	22 Feb 2007	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Common Stock	13,000	$6.13	$79,690
Option	22 Feb 2007	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Stock Option (right to buy)	13,000	$6.13	$79,690
Sale	22 Feb 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,000	$18.4	$18,400
Sale	22 Feb 2007	DAVIS GEORGE ERIC officer: EVP, General Counsel officer: EVP, General Counsel	Common Stock	13,000	$18.38	$238,940
Sale	20 Feb 2007	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	13,000	$16.96	$220,480
Sale	14 Feb 2007	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Common Stock	15,000	$7.16	$107,400
Option	14 Feb 2007	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Common Stock	15,000	$7.16	$107,400
Option	14 Feb 2007	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Stock Option (right to buy)	15,000	$7.16	$107,400
Option	4 Jan 2007	KAKKIS EMIL D officer: Chief Medical Officer officer: Chief Medical Officer	Stock Option (right to buy)	50,000	$4	$200,000
Option	3 Jan 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Stock Option (right to buy)	12,500	$4	$50,000
Sale	3 Jan 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$4	$50,000
Option	3 Jan 2007	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$4	$50,000
Purchase	12 Dec 2006	LAPALME PIERRE director director	Common Stock	4,200	$17.88	$75,113
Sale	6 Dec 2006	COOPER JEFFREY H officer: SVP, Chief Financial Officer officer: SVP, Chief Financial O..	Common Stock	14,500	$8.1	$117,450
Option	6 Dec 2006	COOPER JEFFREY H officer: SVP, Chief Financial Officer officer: SVP, Chief Financial O..	Common Stock	14,500	$8.1	$117,450
Option	6 Dec 2006	COOPER JEFFREY H officer: SVP, Chief Financial Officer officer: SVP, Chief Financial O..	Stock Option (right to buy)	14,500	$8.1	$117,450
Sale	29 Nov 2006	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Common Stock	5,000	$7.16	$35,800
Option	29 Nov 2006	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Common Stock	5,000	$7.16	$35,800
Option	29 Nov 2006	ASELAGE STEVE officer: EVP, Chief Business Officer officer: EVP, Chief Business Of..	Stock Option (right to buy)	5,000	$7.16	$35,800
Sale	1 Nov 2006	SWIEDLER STUART J officer: SVP, Clinical Affairs officer: SVP, Clinical Affairs	Common Stock	12,500	$4	$50,000

Showing 2300 to 2350 of 2449 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

BioMarin Pharmaceutical Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

BioMarin Pharmaceutical
Insider trading & Transactions